News and Announcements
MARK.SPACE receives US$11 million from strategic investors
- Published July 17, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- MARK.SPACE has received USD11 million from strategic investors.
- The MARK.SPACE platform allows users to interact in a 3D world for browsing the internet.
- The company is on track to launch their digital currency and their shopping and residential districts.
MARK.SPACE, a platform that combines VR and blockchain technologies, has announced they have received USD11 million from strategic investors. Founded in 2014, MARK.SPACE has raised over USD 22 million for their platform that enables users to create Virtual Reality (VR) and Augmented Reality (AR) compatible 3D worlds accessible from any device, browser or VR headset. The company is expecting a further USD7 million from another key investor, adding to the growing of the platform. The platform allows users to interact in a 3D world, creating a 70 square virtual reality unit populated with virtual objects and landscapes. The units can be private or public and accessible through a MARK.SPACE unified browser.
MARK.SPACE will officially launch their token, MRK, after an initial coin offering (ICO) late in 2017. The token is only valid within the MARK.SPACE platform. The company is also on schedule to implement their blockchain infrastructure, which will allow the trading and leasing of units along with the sales of goods and services on the platform. MARK.SPACE will launch their residential and shopping districts of the platform in October through to December 2018.
About Mark.Space
MARK.SPACE is a platform for business, e-commerce and communities where everybody can create their own 3D website (unit) which is compatible with VR. You can visit communities, residential, business or e-commerce districts to find services or purchase some goods, or just have fun. The platform is maintained by a crypto economy and is powered by Blockchain.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
